Enbrel Purple Book BLA 103795

BLA number
103795
Proprietary names
Enbrel, Enbrel Mini
Proper names
etanercept
Applicant
Immunex Corporation
Center
CDER
First observed release
2020-02-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Enbreletanercept351(a)25MGFor InjectionSubcutaneousSingle-Dose VialDiscLicensed1998-11-02
002Enbreletanercept351(a)25MGFor InjectionSubcutaneousMulti-Dose VialRxLicensed1999-05-27
003Enbreletanercept351(a)50MG/MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2004-09-27
004Enbreletanercept351(a)25MG/0.5MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2007-02-01
005Enbrel Minietanercept351(a)50MG/MLInjectionSubcutaneousSingle-Dose CartridgeRxLicensed2017-09-14
006Enbreletanercept351(a)50MG/MLInjectionSubcutaneousAutoinjectorRxLicensed
007Enbreletanercept351(a)25MG/0.5MLInjectionSubcutaneousSingle-Dose VialRxLicensed2020-03-05

Biosimilar And Interchangeable Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761042Erelzietanercept-szzs351(k) BiosimilarDisc2026-06-01
761066Eticovoetanercept-ykro351(k) InterchangeableDisc2026-06-01

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2021-03-01U001Enbrel351(a)DiscImmunex Corporation
2020-08-01U001Enbrel351(a)RxImmunex Corporation
2020-08-01U002Enbrel351(a)RxImmunex Corporation
2020-08-01U003Enbrel351(a)RxImmunex Corporation
2020-08-01U004Enbrel351(a)RxImmunex Corporation
2020-08-01U005Enbrel Mini351(a)RxImmunex Corporation
2020-08-01U006Enbrel351(a)RxImmunex Corporation
2020-08-01U007Enbrel351(a)RxImmunex Corporation
2020-05-01U005Enbrel Mini351(a)RxImmunex Corporation
2020-05-01U006Enbrel351(a)RxImmunex Corporation
2020-03-01N007Enbrel351(a)MarketedImmunex Corporation

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2021-03-01001Enbrel351(a)DiscLicensed1998-11-02
2020-05-01001Enbrel351(a)RxLicensed1998-11-02
2020-05-01002Enbrel351(a)RxLicensed1999-05-27
2020-05-01003Enbrel351(a)RxLicensed2004-09-27
2020-05-01004Enbrel351(a)RxLicensed2007-02-01
2020-05-01005Enbrel Mini351(a)RxLicensed2017-09-14
2020-05-01006Enbrel351(a)RxLicensed
2020-05-01007Enbrel351(a)RxLicensed2020-03-05
2020-03-01007Enbrel351(a)MarketedLicensed2020-03-05
2020-02-01001Enbrel351(a)MarketedLicensed1998-11-02
2020-02-01002Enbrel351(a)MarketedLicensed1999-05-27
2020-02-01003Enbrel351(a)MarketedLicensed2004-09-27
2020-02-01004Enbrel351(a)MarketedLicensed2007-02-01
2020-02-01005Enbrel351(a)MarketedLicensed
2020-02-01006Enbrel351(a)MarketedLicensed2017-09-14